Ascletis Pharma Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '26 Mar 12, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	15,811	2,904	1,522	5,153	3,575	3,154
Market Cap Growth	155.19%	90.74%	-70.46%	44.13%	13.38%	-4.03%
Enterprise Value	13,842	665	-1,197	2,236	435	-134
Last Close Price	14.90	3.01	1.46	4.74	3.29	2.87
PS Ratio	6103.57	2126.81	24.42	84.27	37.89	75.87
PB Ratio	7.72	1.39	0.59	1.80	1.07	0.89
P/TBV Ratio	7.77	1.40	0.60	1.81	1.10	0.92
EV/Sales Ratio	-	486.91	-	36.57	4.61	-
Debt / Equity Ratio	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt / Equity Ratio	-0.96	-0.99	-0.98	-0.98	-0.92	-0.91
Net Debt / EBITDA Ratio	4.40	4.98	7.78	7.69	12.21	12.05
Net Debt / FCF Ratio	5.74	5.66	9.98	11.84	16.46	30.22
Asset Turnover	0.00	0.00	0.02	0.02	0.03	0.01
Inventory Turnover	0.27	0.11	2.30	2.05	0.66	1.02
Quick Ratio	14.52	12.82	16.50	23.24	28.26	37.47
Current Ratio	14.57	12.88	16.58	23.52	28.93	38.36
Return on Equity (ROE)	-12.78%	-13.97%	-5.93%	-11.95%	-6.97%	-6.64%
Return on Assets (ROA)	-12.32%	-10.96%	-7.50%	-7.94%	-4.88%	-4.79%
Return on Capital Employed (ROCE)	-22.50%	-20.50%	-13.10%	-13.70%	-8.40%	-8.30%
Earnings Yield	-1.79%	-11.03%	-10.47%	-6.91%	-6.83%	-7.88%
FCF Yield	-2.17%	-12.60%	-16.64%	-4.60%	-5.21%	-3.38%
Buyback Yield / Dilution	6.18%	6.75%	1.19%	0.96%	-5.53%	1.37%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.